US3924628A - Cyrogenic bladder for necrosing tissue cells - Google Patents

Cyrogenic bladder for necrosing tissue cells Download PDF

Info

Publication number
US3924628A
US3924628A US311069A US31106972A US3924628A US 3924628 A US3924628 A US 3924628A US 311069 A US311069 A US 311069A US 31106972 A US31106972 A US 31106972A US 3924628 A US3924628 A US 3924628A
Authority
US
United States
Prior art keywords
bladder
pressure
probe
uterus
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US311069A
Inventor
William Droegemueller
Jr Ralph N Eberhardt
Paul E Bingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US311069A priority Critical patent/US3924628A/en
Application granted granted Critical
Publication of US3924628A publication Critical patent/US3924628A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12Devices for heating or cooling internal body cavities
    • A61F7/123Devices for heating or cooling internal body cavities using a flexible balloon containing the thermal element
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • A61B2017/4216Operations on uterus, e.g. endometrium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/03Automatic limiting or abutting means, e.g. for safety
    • A61B2090/033Abutting means, stops, e.g. abutting on tissue or skin
    • A61B2090/036Abutting means, stops, e.g. abutting on tissue or skin abutting on tissue or skin

Definitions

  • Necrosis means the death of the cells in a tissue.
  • Functional lining of the uterus is that portion of the inner lining of the uterus; the endometrium, to which an embryo might attach. It excludes the portions of the uterine inner lining forming the cervix, to which the embryo usually does not attach.
  • Cryogenic as an adjective is used to refer to temperatures sufficiently low to cause cell necrosis.
  • cryosurgery The use of instruments at extremely low or cryogenic temperatures to treat the human body is referred to as cryosurgery within the medical profession.
  • an instrument cooled to a very low temperature is brought into contact with body tissue and the contiguous or adjacent cells are destroyed by the cryogenic temperature, a result known also as coagulation necrosis.
  • the destruction of a cell is usually effected by the formation of ice within a cell, which is sufficient to kill or irreversibly damage it. It can normally withstand ice formation outside the cell wall; to destroy the cell, ice must be formed inside the cell membrane.
  • a human cell contains both salt, most abundantly sodium chloride, and water.
  • a cell protective mechanism operates to resist internal freezing of the cell. Water is expelled from within the cell through the cell membrane. The expelled water may freeze without permanent damage to the cell, but this protective mechanism results in increasing the saline concentration within the cell, lowering its freezing point and rendering it more difficult to destroy with low temperatures. This process continues, with external ice formation, until the eutectic temperature of the sodium chloride, -2l.2C, is reached. At this temperature ice is formed within the cell and it is effectively destroyed.
  • cryogenic destruction of a cell, or of the tissue which is formed of the cells requires either (a) bringing the interior of the cell to a point below the eutectic temperature of sodium chloride or (b) reducing the cell temperature very quickly so that the cell protective mechanism cannot cope with the temperature change and the cell does not have time to expel sufficient water through the membrane to render its interior solution freeze resistant.
  • the variables are the absolute temperature to which a cell is brought, the rapidity of cell temperature change, and also, not discussed above and imperfectly characterized as yet, the length of time a cell is kept at a specific temperature.
  • Cryosurgical techniques utilizing cryogenic necrosis, have been used in gynecology for the treatment of chronic cervicitis and dysfunctional uterine bleeding by applying an instrument at cryogenic temperature to the affected area.
  • the inner lining of the uterus comprises a layer of endometrium that varies in thickness from 2 to 8 millimeters, and outward from the endometrium is a layer of myometrium, or muscle tissue.
  • the embryo attaches itself to the inner wall or surface of the uterus at some point on the functional lining and is supported and sustained by the endometrium.
  • cryogenic necrosis By substantially destroying the entire endometrial layer throughout the extent of the functional lining of the uterus by cryogenic necrosis, that layer is not capable of sustainingan embryo.
  • the method used to date, however, and described in that article, comprised use of a metal probe having a rather small operative area to successively freeze relatively small areas of the endometrium, eventually covering the entire functional lining. That process was relatively slow and laborious and considerable painstaking effort was required to insure that the entire functional lining was necrosed.
  • the method and apparatus of this invention overcome these disadvantages by providing for cryogenic necrosis of the entire functional uterine endometrium in one application and with complete coverage.
  • a flexible bladder is inserted into the uterus and cryogenic fluid at slightly above atmospheric pressure is circulated through the bladder, expanding it into contact with the entire inner uterine surface and at the same time removing heat from that surface so as to effect coagulation necrosis of the endometrium.
  • FIG. 1 shows in a partially schematic manner a sterilization system suitable for use with liquid nitrogen as a refrigerant
  • FIG. la is a partial sectional view taken approximately along line 1a la of FIG. 1;
  • FIG. 2 shows an alternative method for pressurizing the liquid nitrogen system of FIG. 1;
  • FIG. 3 shows schematically a sterilization system suitable for use with refrigerants that are stored at high pressure
  • FIG. 4 shows an alternate arrangement for storing and supplying the high pressure refrigerant in the system of FIG. 3;
  • FIGS. 5a and 5 b show alternative probe expansion orifices suitable for use with the high pressure refrigerant system of FIGS. 3 and 4;
  • FIGS. through 6e show the insertion sequence of one possible probe package.
  • FIG. 1 shows a uterus 10 distended by an inflated bladder 11 attached to a probe generally indicated as 12.
  • the system uses as a refrigerant liquid nitrogen 13 contained in a Dewar vessel 14 that is closed with a plug 15.
  • the liquid nitrogen and the vaporized gaseous nitrogen that fills space 16 above the liquid in Dewar vessel 14 would normally increase in pressure due to heat conduction through the Dewar vessel walls caus ing liquid nitrogen to vaporize.
  • a vent valve 19 connected to pipe 18 is made such that when pressure in the Dewar vessel exceeds a specified value the valve opens to vent the excessive pressure. In this manner the pressure within the Dewar vessel 14 is controlled to be less than or equal to any preset pressure.
  • vent valve 19 As long as liquid nitrogen exists in the vessel, heat conduction into the liquid nitrogen will cause the vent valve 19 to slowly vent vaporized nitrogen to the atmosphere, maintaining pressure in the Dewar at the specified operating pressure. This pressure is used to force the refrigerant into probe 12. Adequate pressure is maintained in the Dewar throughout the expulsion of all of the refrigerant by causing vapor space 16 to be approximately one-half of the total Dewar volume. As refrigerant is forced from the Dewar, vapor in space 16 expands to a lower pressure until it reaches approximately one-half the original pressure that existed at the initiation of refrigerant flow. Vent valve 19 also provides conventional protection by venting any excessive pressures that should build up through some malfunctron.
  • the passage of return tube 25 surrounds supply tube 22 and bladder 11 is attached to the outside surface of tube 25 by a suitable low temperature cement.
  • the end of supply tube 22 is open to the interior of bladder I l by virtue of orifice 23, and that end of return tube 25 is closed by being joined to the periphery of the end of tube 22.
  • the size of orifice 23 may be quite large, in relation to the diameter of tube 22, since only low pressure gas is being fed through it and it does not act as an expansion orifice.
  • Ports 24, comprising the only openings into return tube 25 or the inside of bladder 11, are located well back from the end of the tubes in order to force the nitrogen expelled from orifice 23 to circulate and absorb heat from bladder 11 before being vented to the atmosphere through return tube 25.
  • the probe 12 and its attached bladder 11 must be sufficiently small, when the bladder is deflated and furled around tube 25, so that it can be conveniently inserted into the uterus through a partially dilated cervix.
  • the bladder should be inflated to a pressure sufficient to insure firm contact with the tissue to be necrosed, for example, the interior uterine surface, but should preferably be maintained at about 2 or 3 p.s.i. to avoid any possible risk of internal injury to the patient. It has been found that maintaining a pressure in the Dewar of between -10 p.s.i. results in adequate flow of the nitrogen and the maintenance of proper bladder pressure, although the precise to be used in any case will, of course, need to be adjusted as a function of the various system parameters.
  • the liquid nitrogen vaporizes in the course of its flow from the Dewar 14 to its exit into bladder 11 at supply tube orifice 23.
  • the system may alternatively be operated by permitting the nitrogen to emerge from orifice 23 as a liquid, and allowing it to vaporize in bladder 11.
  • Bladder 11 must be capable of withstanding cryogenic temperatures without rupturing, and should have as good heat transfer characteristics as obtainable in such materials to provide efficient freezing action.
  • a bladder molded of a heat curing rubber bearing General Electric identification SE-5553 has been found satisfactory.
  • FIG. 2 shows alternative methods of providing the required pressurization of theDewar in the system of FIG. 1 in which liquid nitrogen is the refrigerant.
  • one alternate method that may be used to pressurize the vessel 14 is an external source of pressure 52 which is connected with vertical pipe 18 through pipe 51. Pipe 18 feeds down through plug 15 and pressurizes the Dewar l4. Vent valve 19 provides conventional protection by venting the Dewar 14 to the atmosphere should excessive pressure build-up through some malfunction.
  • a second alternative method of providing the required pressurization of the Dewar 14 is also shown in FIG. 2.
  • the vessel may be pressurized by energizing a heater coil 28 that is submerged in the liquid nitrogen 13 by means of a source of power 29 via wires 30.
  • FIG. 3 is a schematic diagram of another system embodiment in which slightly different type of refrigerant is used, that is, a high pressure refrigerant, rather than the liquid nitrogen of the FIG. 1 embodiment which is maintained at atmospheric pressure in a Dewar vessel as described above.
  • the high pressure refrigerants are stored at high pressure in liquid form in non-vented bottles of high strength. The liquid boils away until the vapor pressure in the bottle is equal to the saturation pressure; the refrigerant then is stored as a liquid at room temperature under its own vaporpressure, so that no Dewar vessel is necessary.
  • Freon 13 and Freon 23, supplied by Dupont, and nitrous oxide, are refrigerants useful for this system in the embodiment shown in FIG. 3.
  • the Freons have a vapor pressure in the neighborhood of 500 p.s.i. and nitrous 0xide, in the neighborhood of 700 p.s.i. at room temperature.
  • Liquid nitrogen is not suitable for storage at room temperature because its vapor pressure is so high that providing storage containers of sufficient strength is not feasible.
  • FIG. 3 a bottle 32 is shown containing both a liquid refrigerant 33 such as Freon or nitrous oxideand gas 34.
  • a liquid refrigerant 33 such as Freon or nitrous oxideand gas 34.
  • outlet valve 35 is opened and the high pressure gas is forced through line 36,
  • Probe 39 which is merely indicated schematically in FIG. 3, is similar to the probe described in connection with the embodiment of FIG. 1 including the bladder, except that it is provided with expansion orifices, as shown in FIGS. a and 5b, rather than with the rather large supply tube orifice 23 shown in FIG. 1. This is necessary because the nitrogen of the FIG.
  • FIG. 5a shows a small single expansion orifice 41 located in the end of supply tube 22 and suitable for use in the probe 39 of the high pressure embodiment of FIG. 3.
  • multiple expansion orifices 42 may alternatively be used.
  • an orifice 23 of 0.070 inch has been found suitable for the liquid nitrogen system of FIG. 1.
  • the single expansion orifice (41 of FIG. 5a) of 0.0135 inch has been used for both nitrous oxide and Freon 13 and Freon 23.
  • Two 0.0135 inch expansion orifices (42 of FIG. 5b) or, alternatively, a single orifice (41 of FIG. 6a) of 0.024 inch have been used with both Freons.
  • the three-way valve 37 is used in connection with the warming of the bladder 11 after the cryogenic necrosis has been effected and prior to removal of the instrument from the uterus.
  • I-Iuman tissue is in large part water and when it is in contact with any object at a temperature below the freezing point of water it sticks to the object by freezing to it, and will tend to tear if the object is pulled away.
  • bladder l l which is configured to contact substantially the entire area of tissue to be necrosed, must be warmed before it can be removed, so that the contacted tissue is not torn.
  • the warming is accomplished by stopping the flow or circulation of cryogenic nitrogen into probe 12 and permitting the heat of the patients body to bring the bladder temperature up.
  • the action of body heat in warming bladder 11 is assisted by circulating room temperature gas through the bladder. This is accomplished by moving the threeway valve 37.
  • the valve as shown schematically in FIG. 3, is in a position to pass the refrigerant gas from line 36 directly to line 38.
  • the gas from line 36 will be diverted by valve 37 down into a regulator 43, which may be a Norgren Company Model 11-Ol0-084.
  • Regulator 43 reduces the pressure of the gas to about 50 p.s.i.
  • FIG. 4 illustrates an alternative refrigerant feed arrangement for the high pressure embodiment of FIG. 3 wherein some additional cooling capacity is obtained.
  • a high pressure storage bottle 44 is shown in an inverted position, so that its outlet, and the associated outlet valve 45, are located at the bottom of the bottle.
  • liquid refrigerant, rather than gas is fed from the bottle. This change of state from liquid to gas provides some additional cooling to that obtained by the gaseous expansion during emission from the probe expansion orifices.
  • the bladder material SE-5553 supplied by General Electric and found satisfactory for the embodiment of FIG. 1 is also satisfactory for the FIG. 3 embodiment, where the refrigerant temperaturees are not nearly as low: nitrogen boils at 320.4F; nitrous oxide at -l29.1F; Freon 13 at l14.6F and Freon 23 at -1 15.7F.
  • a dispersion coating rubber supplied by Dow Corning to their number 92-009 has been found satisfactory for use with the high pressure (and higher temperature) refrigerants of the FIG. 3 embodiment.
  • Bladders of approximately 0.020 inch thickness have been found satisfactory.
  • Various methodsof fabricating the bladder may be employed, but one method found satisfactory has been to lay up the bladder in successive thin layers upon a mandrel.
  • thermocouples 50 FIG. 1a
  • the thermocouples 50 and their leads may be placed between successive layers as the bladder is formed.
  • Such thermocouples are connected to appropriate instrumentation for monitoring bladder temperature.
  • the embodiments of FIGS. 1 and 3 each have advantages and disadvantages so that neither can clearly be preferred to the other.
  • the liquid nitrogen refrigerant of the FIG. 1 embodiment provides a much lower temperature and consequently faster tissue freezing. It, however, has the disadvantages of imposing more constraints upon system components, especially the bladder, because of the lower temperature, and it requires the inconvenience of low temperature refrigerant storage.
  • the high pressure refrigerants, on the other hand, useful in the FIG. 3 embodiment are conveniently stored at room temperature, are generally more readily available than liquid nitrogen, but compare unfavorably with liquid nitrogen in having higher temperatures and consequently slower freezing.
  • the procedure is as follows.
  • the cervix is visualized and then grasped with a tenaculum.
  • the cervix is dilated with instruments to approximately one centimeter.
  • probe 12 with bladder 11 furled tightly around it, is inserted through the cervix into the uterus.
  • the refrigerant is applied to probe 12 for a sufficient period to accomplish cryogenic necrosis of the functional endometrium.
  • the bladder 11 is then warmed and removed.
  • FIGS. 6a through 6e shows in sequential steps the ap' plication of one configuration in which either of the embodiments of FIG. 1 or FIG. 3 may be packaged: a tampon-type cartridge.
  • FIG. 6a shows the package, comprising a handle" portion, which is comprised of supply tube 22 and return tube 25, the bladder 11 furled tightly around the end of return tube 25, and encased in a cylindrical sleeve 48 terminating in an annular shoulder 49.
  • the outside diameter of the sleeve should be less than one centimeter so that it may be readily inserted into the partially dilated cervical openmg.
  • FIG. 6b shows the sleeve 48 containing the furled probe being inserted into the opening in the cervix 55.
  • sleeve 48 has been fully inserted into the cervix 55, being stopped by the abutment of the sleeve shoulder 49 against the outer cervical surface.
  • the probe has been advanced so that the end of the probe with the furled bladder 11 has been pushed free of sleeve 48 and is positioned inside the uterus.
  • bladder 11 inflates and assumes the position inside the uterus shown by FIG. 6d, showing a view along a vertical plane through the body, and FIG. 6e, showing a view along a horizontal plane through the body.
  • the primary feature of the package of FIG. 6 is the use of the flanged sleeve 48.
  • This sleeve which is preferably about 2.5 centimeters in length, is used to protect the bladder from mechanical damage during storage and handling prior to use and also as an insertion aid. Since the inner uterine surface within about 2.5 centimeters of the cervix opening is not part of the functional uterine lining and should not be necrosed, the insulating effect of the sleeve will protect this portion of the uterus and prevent an unnecessary loss of cooling capacity.
  • a method of effecting coagulation necrosis of the functional uterine endometrium comprising the steps of:

Abstract

A method of, and apparatus for necrosing human tissue cells are described in which an expandable bladder filled with a fluid at a cyrogenic temperature is used to subject the entire area of tissue in contact with the bladder to temperatures sufficiently low to cause coagulation necrosis, whereby the entire contacted area of tissue is simultaneously necrosed. As an example, this apparatus can be utilized to cause sterilization by necrosis of the entire functional endometrial layer of the uterus of a human female.

Description

Sheet 1 of3 U.S. Patent Dec. 9, 1975 U.S. Patent Dec. 9, 1975 Sheet 2 of3 3,924,628
Fig 5b US. Patent Dec 9, 1975 Sheet 3 of3 3,924,628
CYROGENIC BLADDER FOR NECROSING TISSUE CELLS DEFINITIONS The following terms are used herein as having the meanings given below:
Necrosis" means the death of the cells in a tissue.
Functional lining of the uterus is that portion of the inner lining of the uterus; the endometrium, to which an embryo might attach. It excludes the portions of the uterine inner lining forming the cervix, to which the embryo usually does not attach.
Cryogenic as an adjective is used to refer to temperatures sufficiently low to cause cell necrosis.
BACKGROUND OF THE INVENTION The use of instruments at extremely low or cryogenic temperatures to treat the human body is referred to as cryosurgery within the medical profession. In cryosurgery, an instrument cooled to a very low temperature is brought into contact with body tissue and the contiguous or adjacent cells are destroyed by the cryogenic temperature, a result known also as coagulation necrosis. The destruction of a cell is usually effected by the formation of ice within a cell, which is sufficient to kill or irreversibly damage it. It can normally withstand ice formation outside the cell wall; to destroy the cell, ice must be formed inside the cell membrane.
A human cell contains both salt, most abundantly sodium chloride, and water. As the external environment of the cell is cooled, a cell protective mechanism operates to resist internal freezing of the cell. Water is expelled from within the cell through the cell membrane. The expelled water may freeze without permanent damage to the cell, but this protective mechanism results in increasing the saline concentration within the cell, lowering its freezing point and rendering it more difficult to destroy with low temperatures. This process continues, with external ice formation, until the eutectic temperature of the sodium chloride, -2l.2C, is reached. At this temperature ice is formed within the cell and it is effectively destroyed.
Therefore, in light of the above, cryogenic destruction of a cell, or of the tissue which is formed of the cells, requires either (a) bringing the interior of the cell to a point below the eutectic temperature of sodium chloride or (b) reducing the cell temperature very quickly so that the cell protective mechanism cannot cope with the temperature change and the cell does not have time to expel sufficient water through the membrane to render its interior solution freeze resistant. In cryogenic necrosis then, the variables are the absolute temperature to which a cell is brought, the rapidity of cell temperature change, and also, not discussed above and imperfectly characterized as yet, the length of time a cell is kept at a specific temperature.
Cryosurgical techniques, utilizing cryogenic necrosis, have been used in gynecology for the treatment of chronic cervicitis and dysfunctional uterine bleeding by applying an instrument at cryogenic temperature to the affected area.
Present procedures for permanent sterilization of the human female involve major surgery to enter the abdominal cavity. The attendant disadvantages are obvi ous and are those of most surgical procedures: the inconvenience and cost of a hospital stay; and the high cost of services of a surgeon and "other professionals.
It is the object of this invention to make available less expensive sterilization of human females by providing a sterilization procedure that may be performed more quickly than present surgical sterilization techniques and will not require the attendance of an entire surgical team or their support facilities.
The inner lining of the uterus comprises a layer of endometrium that varies in thickness from 2 to 8 millimeters, and outward from the endometrium is a layer of myometrium, or muscle tissue. After conception, the embryo attaches itself to the inner wall or surface of the uterus at some point on the functional lining and is supported and sustained by the endometrium. By substantially destroying the entire endometrial layer throughout the extent of the functional lining of the uterus by cryogenic necrosis, that layer is not capable of sustainingan embryo. An article, entitled Destruction of the Endometrium by Cryosurgery, by W. Droegemueller, E. Makowski and R. Macsalka, appearing in the American Journal of Obstetrics and Gynecology, Vol. 110, No. 4, June 15, 1971, describes cryogenic necrosis of the uterine endometrium.
The method used to date, however, and described in that article, comprised use of a metal probe having a rather small operative area to successively freeze relatively small areas of the endometrium, eventually covering the entire functional lining. That process was relatively slow and laborious and considerable painstaking effort was required to insure that the entire functional lining was necrosed. The method and apparatus of this invention overcome these disadvantages by providing for cryogenic necrosis of the entire functional uterine endometrium in one application and with complete coverage. A flexible bladder is inserted into the uterus and cryogenic fluid at slightly above atmospheric pressure is circulated through the bladder, expanding it into contact with the entire inner uterine surface and at the same time removing heat from that surface so as to effect coagulation necrosis of the endometrium.
The nature of the inventive method and apparatus is set forth in greater detail in the description below taken in conjunction with the drawings, which form a part of the specification, and in which:
FIG. 1 shows in a partially schematic manner a sterilization system suitable for use with liquid nitrogen as a refrigerant;
FIG. la is a partial sectional view taken approximately along line 1a la of FIG. 1;
FIG. 2 shows an alternative method for pressurizing the liquid nitrogen system of FIG. 1;
FIG. 3 shows schematically a sterilization system suitable for use with refrigerants that are stored at high pressure;
FIG. 4 shows an alternate arrangement for storing and supplying the high pressure refrigerant in the system of FIG. 3;
FIGS. 5a and 5 b show alternative probe expansion orifices suitable for use with the high pressure refrigerant system of FIGS. 3 and 4;
FIGS. through 6e show the insertion sequence of one possible probe package.
FIG. 1 shows a uterus 10 distended by an inflated bladder 11 attached to a probe generally indicated as 12. The system uses as a refrigerant liquid nitrogen 13 contained in a Dewar vessel 14 that is closed with a plug 15. The liquid nitrogen and the vaporized gaseous nitrogen that fills space 16 above the liquid in Dewar vessel 14 would normally increase in pressure due to heat conduction through the Dewar vessel walls caus ing liquid nitrogen to vaporize. A vent valve 19 connected to pipe 18 is made such that when pressure in the Dewar vessel exceeds a specified value the valve opens to vent the excessive pressure. In this manner the pressure within the Dewar vessel 14 is controlled to be less than or equal to any preset pressure. As long as liquid nitrogen exists in the vessel, heat conduction into the liquid nitrogen will cause the vent valve 19 to slowly vent vaporized nitrogen to the atmosphere, maintaining pressure in the Dewar at the specified operating pressure. This pressure is used to force the refrigerant into probe 12. Adequate pressure is maintained in the Dewar throughout the expulsion of all of the refrigerant by causing vapor space 16 to be approximately one-half of the total Dewar volume. As refrigerant is forced from the Dewar, vapor in space 16 expands to a lower pressure until it reaches approximately one-half the original pressure that existed at the initiation of refrigerant flow. Vent valve 19 also provides conventional protection by venting any excessive pressures that should build up through some malfunctron.
Pressure in excess of atmospheric applied to the surface of liquid nitrogen 13 forces it up into vertical pipe 20, through valve 17 and flexible tubing 21 and into supply tube 22 of probe 12. In the course of passage through these tubes, the liquid nitrogen evaporates and forms gaseous nitrogen. The nitrogen fluid emerges from orifice 23 at the end of supply tube 22 and flows into bladder Ill, forcing it to expand into contact with the inner surface of uterus 10. The cold nitrogen gas absorbs heat from bladder 11 and then flows through ports 24 into return tube 25 and is vented to the atmosphere at the open end 26 of tube 25. The arrows in FIG. 1 indicate the flow of nitrogen in probe 12. Supply tube 22 and return tube 25 are rigid or semi-rigid coaxial tubes. The passage of return tube 25 surrounds supply tube 22 and bladder 11 is attached to the outside surface of tube 25 by a suitable low temperature cement. The end of supply tube 22 is open to the interior of bladder I l by virtue of orifice 23, and that end of return tube 25 is closed by being joined to the periphery of the end of tube 22. The size of orifice 23 may be quite large, in relation to the diameter of tube 22, since only low pressure gas is being fed through it and it does not act as an expansion orifice. Ports 24, comprising the only openings into return tube 25 or the inside of bladder 11, are located well back from the end of the tubes in order to force the nitrogen expelled from orifice 23 to circulate and absorb heat from bladder 11 before being vented to the atmosphere through return tube 25.
The probe 12 and its attached bladder 11 must be sufficiently small, when the bladder is deflated and furled around tube 25, so that it can be conveniently inserted into the uterus through a partially dilated cervix. The bladder should be inflated to a pressure sufficient to insure firm contact with the tissue to be necrosed, for example, the interior uterine surface, but should preferably be maintained at about 2 or 3 p.s.i. to avoid any possible risk of internal injury to the patient. It has been found that maintaining a pressure in the Dewar of between -10 p.s.i. results in adequate flow of the nitrogen and the maintenance of proper bladder pressure, although the precise to be used in any case will, of course, need to be adjusted as a function of the various system parameters.
In the system described above, the liquid nitrogen vaporizes in the course of its flow from the Dewar 14 to its exit into bladder 11 at supply tube orifice 23. However, the system may alternatively be operated by permitting the nitrogen to emerge from orifice 23 as a liquid, and allowing it to vaporize in bladder 11.
Bladder 11 must be capable of withstanding cryogenic temperatures without rupturing, and should have as good heat transfer characteristics as obtainable in such materials to provide efficient freezing action. A bladder molded of a heat curing rubber bearing General Electric identification SE-5553 has been found satisfactory.
Testing conducted to date indicates that with the system shown in FIG. 1, the exterior surface of the bladder when completely enclosed in a warm liver reached 73C within five minutes from the start of circulating the nitrogen in the bladder. Based on prior medical testing, at this temperature complete cell necrosis would occur within 2 to 4 minutes. This causes sterilization to be effected.
FIG. 2 shows alternative methods of providing the required pressurization of theDewar in the system of FIG. 1 in which liquid nitrogen is the refrigerant. Instead of allowing the Dewar to become pressurized due to heat conduction, as shown in FIG. 1, one alternate method that may be used to pressurize the vessel 14 is an external source of pressure 52 which is connected with vertical pipe 18 through pipe 51. Pipe 18 feeds down through plug 15 and pressurizes the Dewar l4. Vent valve 19 provides conventional protection by venting the Dewar 14 to the atmosphere should excessive pressure build-up through some malfunction.
A second alternative method of providing the required pressurization of the Dewar 14 is also shown in FIG. 2. Instead of applying an external pressure to the Dewar, the vessel may be pressurized by energizing a heater coil 28 that is submerged in the liquid nitrogen 13 by means of a source of power 29 via wires 30. The
heat generated by the coil causes the liquid nitrogen to vaporize and the vessel pressure accordingly increases and forces the liquid nitrogen through the pipe 20 and tubing system and into the probe 12.
FIG. 3 is a schematic diagram of another system embodiment in which slightly different type of refrigerant is used, that is, a high pressure refrigerant, rather than the liquid nitrogen of the FIG. 1 embodiment which is maintained at atmospheric pressure in a Dewar vessel as described above. The high pressure refrigerants, on the contrary, are stored at high pressure in liquid form in non-vented bottles of high strength. The liquid boils away until the vapor pressure in the bottle is equal to the saturation pressure; the refrigerant then is stored as a liquid at room temperature under its own vaporpressure, so that no Dewar vessel is necessary. Freon 13 and Freon 23, supplied by Dupont, and nitrous oxide, are refrigerants useful for this system in the embodiment shown in FIG. 3. The Freons have a vapor pressure in the neighborhood of 500 p.s.i. and nitrous 0xide, in the neighborhood of 700 p.s.i. at room temperature. Liquid nitrogen, on the other hand, is not suitable for storage at room temperature because its vapor pressure is so high that providing storage containers of sufficient strength is not feasible.
In FIG. 3 a bottle 32 is shown containing both a liquid refrigerant 33 such as Freon or nitrous oxideand gas 34. To operate the system, outlet valve 35 is opened and the high pressure gas is forced through line 36,
through a thrce-way valve 37, and through line 38, into probe 39. Lines 36 and 38 preferablyinclude sections of flexible hose. When the high pressure refrigerant gas reaches probe 39 it is emitted from a small expansion orifice or nozzle and the resulting gaseous expansion causes the cooling. Probe 39, which is merely indicated schematically in FIG. 3, is similar to the probe described in connection with the embodiment of FIG. 1 including the bladder, except that it is provided with expansion orifices, as shown in FIGS. a and 5b, rather than with the rather large supply tube orifice 23 shown in FIG. 1. This is necessary because the nitrogen of the FIG. 1 embodiment is already at cryogenic temperature since it is stored at cryogenic temperature, and cannot lose any heat through expansion on going from high to low pressure, since it is already at a low (substantially atmospheric) pressure. The high pressure refrigerants of the FIG. 3 embodiment, however, since they are stored at room temperature, must obtain their cooling from the expansion of the gas as it is emitted from a high pressure line through a small expansion orifice into the low pressure interior of bladder 11.
FIG. 5a shows a small single expansion orifice 41 located in the end of supply tube 22 and suitable for use in the probe 39 of the high pressure embodiment of FIG. 3. Instead of the single orifice of FIG. 5a, multiple expansion orifices 42, as shown in FIG. 5b, may alternatively be used. As examples of the sizes of orifices suitable for the systems described, an orifice 23 of 0.070 inch has been found suitable for the liquid nitrogen system of FIG. 1. In the high pressure system of FIG. 3, the single expansion orifice (41 of FIG. 5a) of 0.0135 inch has been used for both nitrous oxide and Freon 13 and Freon 23. Two 0.0135 inch expansion orifices (42 of FIG. 5b) or, alternatively, a single orifice (41 of FIG. 6a) of 0.024 inch have been used with both Freons.
The three-way valve 37 is used in connection with the warming of the bladder 11 after the cryogenic necrosis has been effected and prior to removal of the instrument from the uterus. I-Iuman tissue is in large part water and when it is in contact with any object at a temperature below the freezing point of water it sticks to the object by freezing to it, and will tend to tear if the object is pulled away. For this reason, after the cryogenic or freezing cycle of probe 12, in both the embodiments of FIGS. 1 and 3, bladder l l, which is configured to contact substantially the entire area of tissue to be necrosed, must be warmed before it can be removed, so that the contacted tissue is not torn.
In the liquid nitrogen embodiment of FIG. 1 the warming is accomplished by stopping the flow or circulation of cryogenic nitrogen into probe 12 and permitting the heat of the patients body to bring the bladder temperature up. In the high pressure embodiment of FIG. 3, the action of body heat in warming bladder 11 is assisted by circulating room temperature gas through the bladder. This is accomplished by moving the threeway valve 37. The valve, as shown schematically in FIG. 3, is in a position to pass the refrigerant gas from line 36 directly to line 38. By rotating the valve 37 one quarter turn in the counterclockwise direction as shown in FIG. 3, the gas from line 36 will be diverted by valve 37 down into a regulator 43, which may be a Norgren Company Model 11-Ol0-084. Regulator 43 reduces the pressure of the gas to about 50 p.s.i. and then feeds it on through line 38 to probe 39. The gas flows through expansion orifices 41 or 42, but since it is already at a very low pressure, there is hardly any expansion or cooling, and the relatively warm gas flowing through the interior of bladder 11 hastens its warming.
FIG. 4 illustrates an alternative refrigerant feed arrangement for the high pressure embodiment of FIG. 3 wherein some additional cooling capacity is obtained. A high pressure storage bottle 44 is shown in an inverted position, so that its outlet, and the associated outlet valve 45, are located at the bottom of the bottle. In this embodiment liquid refrigerant, rather than gas, is fed from the bottle. This change of state from liquid to gas provides some additional cooling to that obtained by the gaseous expansion during emission from the probe expansion orifices.
The bladder material SE-5553 supplied by General Electric and found satisfactory for the embodiment of FIG. 1 is also satisfactory for the FIG. 3 embodiment, where the refrigerant temperaturees are not nearly as low: nitrogen boils at 320.4F; nitrous oxide at -l29.1F; Freon 13 at l14.6F and Freon 23 at -1 15.7F. In addition a dispersion coating rubber supplied by Dow Corning to their number 92-009 has been found satisfactory for use with the high pressure (and higher temperature) refrigerants of the FIG. 3 embodiment. Bladders of approximately 0.020 inch thickness have been found satisfactory. Various methodsof fabricating the bladder may be employed, but one method found satisfactory has been to lay up the bladder in successive thin layers upon a mandrel. This method of fabrication also facilitates placing one or more thermocouples 50 (FIG. 1a) in the bladder. The thermocouples 50 and their leads may be placed between successive layers as the bladder is formed. Such thermocouples are connected to appropriate instrumentation for monitoring bladder temperature. The embodiments of FIGS. 1 and 3 each have advantages and disadvantages so that neither can clearly be preferred to the other. The liquid nitrogen refrigerant of the FIG. 1 embodiment provides a much lower temperature and consequently faster tissue freezing. It, however, has the disadvantages of imposing more constraints upon system components, especially the bladder, because of the lower temperature, and it requires the inconvenience of low temperature refrigerant storage. The high pressure refrigerants, on the other hand, useful in the FIG. 3 embodiment, are conveniently stored at room temperature, are generally more readily available than liquid nitrogen, but compare unfavorably with liquid nitrogen in having higher temperatures and consequently slower freezing.
In using the cryogenic system of either FIGS. 1 or 3 to sterilize a female, the procedure is as follows. The cervix is visualized and then grasped with a tenaculum. Then the cervix is dilated with instruments to approximately one centimeter. Then probe 12, with bladder 11 furled tightly around it, is inserted through the cervix into the uterus. The refrigerant is applied to probe 12 for a sufficient period to accomplish cryogenic necrosis of the functional endometrium. The bladder 11 is then warmed and removed.
FIGS. 6a through 6e shows in sequential steps the ap' plication of one configuration in which either of the embodiments of FIG. 1 or FIG. 3 may be packaged: a tampon-type cartridge. FIG. 6a shows the package, comprising a handle" portion, which is comprised of supply tube 22 and return tube 25, the bladder 11 furled tightly around the end of return tube 25, and encased in a cylindrical sleeve 48 terminating in an annular shoulder 49. The outside diameter of the sleeve should be less than one centimeter so that it may be readily inserted into the partially dilated cervical openmg.
FIG. 6b shows the sleeve 48 containing the furled probe being inserted into the opening in the cervix 55. In the next step, shown in FIG. 60, sleeve 48 has been fully inserted into the cervix 55, being stopped by the abutment of the sleeve shoulder 49 against the outer cervical surface. Also in FIG. 6c, the probe has been advanced so that the end of the probe with the furled bladder 11 has been pushed free of sleeve 48 and is positioned inside the uterus. When the refrigerant is applied to probe 12, bladder 11 inflates and assumes the position inside the uterus shown by FIG. 6d, showing a view along a vertical plane through the body, and FIG. 6e, showing a view along a horizontal plane through the body.
The primary feature of the package of FIG. 6 is the use of the flanged sleeve 48. This sleeve, which is preferably about 2.5 centimeters in length, is used to protect the bladder from mechanical damage during storage and handling prior to use and also as an insertion aid. Since the inner uterine surface within about 2.5 centimeters of the cervix opening is not part of the functional uterine lining and should not be necrosed, the insulating effect of the sleeve will protect this portion of the uterus and prevent an unnecessary loss of cooling capacity.
While certain illustrative embodiments and details thereof have been set forth herein, various changes and modifications thereto as will occur to those skilled in the art may be made without departing from the scope of the invention, which is defined only in the appended claims. For example, although the embodiments of the invention have been described in detail in connection with the female sterilization application, it should be appreciated that by appropriately configuring the bladder, tissue other than the uterine lining tissue can be necrosed and the uterus lining or a portion thereof may be necrosed for purposes other than sterilization such as for treating dysfunctional uterine bleeding.
What is claimed is:
l. A method of effecting coagulation necrosis of the functional uterine endometrium comprising the steps of:
a. inserting a flexible bladder in the uterus;
b. inflating said bladder with a fluid at cryogenic temperature so that said bladder is in substantially continuous contact with the inner surface of the functional uterine lining, said fluid undergoing a phase change to extract heat from said functional uterine endometrium; and
. maintaining said bladder. so inflated with said fluid at said cryogenic temperature for a period of time sufficient for said heat extraction to effect simultaneous coagulation necrosis of substantially all of the functional uterine endometrium.
2. A method as defined in claim 1 wherein the exte- 0 rior of said bladder in contact with said lining is main-

Claims (2)

1. A method of effecting coagulation necrosis of the functional uterine endometrium comprising the steps of: a. inserting a flexible bladder in the uterus; b. inflating said bladder with a fluid at cryogenic temperature so that said bladder is in substantially continuous contact with the inner surface of the functional uterine lining, said fluid undergoing a phase change to extract heat from said functional uterine endometrium; and c. maintaining said bladder so inflated with said fluid at said cryogenic temperature for a period of time sufficient for said heat extraction to effect simultaneous coagulation necrosis of substantially all of the functional uterine endometrium.
2. A method as defined in claim 1 wherein the exterior of said bladder in contact with said lining is maintained at least -73*C for at least 2 minutes.
US311069A 1972-12-01 1972-12-01 Cyrogenic bladder for necrosing tissue cells Expired - Lifetime US3924628A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US311069A US3924628A (en) 1972-12-01 1972-12-01 Cyrogenic bladder for necrosing tissue cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US311069A US3924628A (en) 1972-12-01 1972-12-01 Cyrogenic bladder for necrosing tissue cells

Publications (1)

Publication Number Publication Date
US3924628A true US3924628A (en) 1975-12-09

Family

ID=23205251

Family Applications (1)

Application Number Title Priority Date Filing Date
US311069A Expired - Lifetime US3924628A (en) 1972-12-01 1972-12-01 Cyrogenic bladder for necrosing tissue cells

Country Status (1)

Country Link
US (1) US3924628A (en)

Cited By (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275734A (en) * 1977-08-12 1981-06-30 Valleylab, Inc. Cryosurgical apparatus and method
US4367743A (en) * 1976-05-24 1983-01-11 Virginia M. Gregory Self-pressurizing cryogenic apparatus and method
US4646735A (en) * 1985-10-04 1987-03-03 Seney John S Pain-alleviating tissue treatment assembly
US4865028A (en) * 1987-03-05 1989-09-12 Swart Wilhelmus J B Device for carrying out a therapeutic treatment by means of a refrigerant
US4949718A (en) * 1988-09-09 1990-08-21 Gynelab Products Intrauterine cauterizing apparatus
US5084044A (en) * 1989-07-14 1992-01-28 Ciron Corporation Apparatus for endometrial ablation and method of using same
US5108390A (en) * 1988-11-14 1992-04-28 Frigitronics, Inc. Flexible cryoprobe
US5195965A (en) * 1991-03-07 1993-03-23 Shantha Totada R Method and apparatus for localized treatment of human viral infections and cancers
US5211631A (en) * 1991-07-24 1993-05-18 Sheaff Charles M Patient warming apparatus
US5242390A (en) * 1991-05-03 1993-09-07 Goldrath Milton H Endometrium coagulating surgical method for thermal destruction of the endometrium
US5277201A (en) * 1992-05-01 1994-01-11 Vesta Medical, Inc. Endometrial ablation apparatus and method
GB2269107A (en) * 1992-07-31 1994-02-02 Spembly Medical Ltd Cryosurgical ablation
EP0624347A1 (en) * 1993-05-10 1994-11-17 Browning Healthcare Limited Cryoprobe
US5366490A (en) * 1992-08-12 1994-11-22 Vidamed, Inc. Medical probe device and method
US5385544A (en) * 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US5409453A (en) * 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
WO1995013026A1 (en) * 1993-11-12 1995-05-18 Neuwirth Robert S Intrauterine cryoablation cauterizing apparatus and method
US5421819A (en) * 1992-08-12 1995-06-06 Vidamed, Inc. Medical probe device
US5435805A (en) * 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5437629A (en) * 1994-04-14 1995-08-01 Bei Medical Systems Fluid delivery system for hysteroscopic endometrial ablation
US5443470A (en) * 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5449380A (en) * 1993-09-17 1995-09-12 Origin Medsystems, Inc. Apparatus and method for organ ablation
US5456662A (en) * 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US5470308A (en) * 1992-08-12 1995-11-28 Vidamed, Inc. Medical probe with biopsy stylet
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5514131A (en) * 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5522870A (en) * 1993-01-25 1996-06-04 State Of Israel, Ministry Of Defense, Rafael-Armaments Development Authority Fast changing heating-cooling device and method
US5540679A (en) * 1992-10-05 1996-07-30 Boston Scientific Corporation Device and method for heating tissue in a patient's body
US5540062A (en) * 1993-11-01 1996-07-30 State Of Israel, Ministry Of Defence, Rafael Armaments Development Authority Controlled cryogenic contact system
US5542915A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US5556377A (en) * 1992-08-12 1996-09-17 Vidamed, Inc. Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5562720A (en) * 1992-05-01 1996-10-08 Vesta Medical, Inc. Bipolar/monopolar endometrial ablation device and method
US5575788A (en) * 1994-06-24 1996-11-19 Stuart D. Edwards Thin layer ablation apparatus
US5599295A (en) * 1992-08-12 1997-02-04 Vidamed, Inc. Medical probe apparatus with enhanced RF, resistance heating, and microwave ablation capabilities
US5630794A (en) * 1992-08-12 1997-05-20 Vidamed, Inc. Catheter tip and method of manufacturing
US5672153A (en) * 1992-08-12 1997-09-30 Vidamed, Inc. Medical probe device and method
US5681308A (en) * 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5693077A (en) * 1994-09-21 1997-12-02 Friedman; Mark H. Treatment of vascular and tension headache atypical facial pain allergic rhinitis and cervical muscle hyperactivity
US5720719A (en) * 1992-08-12 1998-02-24 Vidamed, Inc. Ablative catheter with conformable body
US5769880A (en) * 1996-04-12 1998-06-23 Novacept Moisture transport system for contact electrocoagulation
US5800493A (en) * 1995-04-26 1998-09-01 Gynecare, Inc. Intrauterine ablation system
WO1998046148A1 (en) * 1997-04-14 1998-10-22 The Johns Hopkins University Endoscopic cryospray device
US5891457A (en) * 1997-05-12 1999-04-06 Neuwirth; Robert S. Intrauterine chemical necrosing method, composition, and apparatus
US5957917A (en) * 1995-01-20 1999-09-28 Miravant Systems, Inc. Transluminal hyperthermia catheter and method for use
WO1999060960A1 (en) * 1998-05-22 1999-12-02 James Elliott Endometrial ablation method and apparatus
US6027499A (en) * 1997-05-23 2000-02-22 Fiber-Tech Medical, Inc. (Assignee Of Jennifer B. Cartledge) Method and apparatus for cryogenic spray ablation of gastrointestinal mucosa
US6066132A (en) * 1998-06-30 2000-05-23 Ethicon, Inc. Articulating endometrial ablation device
US6161543A (en) * 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US6182666B1 (en) 1996-12-26 2001-02-06 Cryogen, Inc. Cryosurgical probe and method for uterine ablation
US6187346B1 (en) 1995-06-07 2001-02-13 Ablation Products, Inc. Intrauterine chemical cauterizing method and composition
US6197351B1 (en) 1995-06-07 2001-03-06 Robert S. Neuwirth Intrauterine chemical necrosing method and composition
US6224591B1 (en) 1995-03-01 2001-05-01 Atos Medical Ab Device and method for hyperthermia treatment
US6270494B1 (en) 1996-12-26 2001-08-07 Cryogen, Inc. Stretchable cryoprobe sheath
US6306129B1 (en) 1997-09-22 2001-10-23 Femrx, Inc. Cryosurgical system and method
US6395012B1 (en) * 2000-05-04 2002-05-28 Inbae Yoon Apparatus and method for delivering and deploying an expandable body member in a uterine cavity
US6443947B1 (en) 2000-03-01 2002-09-03 Alexei Marko Device for thermal ablation of a cavity
US6530234B1 (en) 1995-10-12 2003-03-11 Cryogen, Inc. Precooling system for Joule-Thomson probe
US6547784B1 (en) * 2000-06-23 2003-04-15 Ethicon, Inc. System and method for placement of a surgical instrument in a body cavity
US6551274B2 (en) 2000-02-29 2003-04-22 Biosense Webster, Inc. Cryoablation catheter with an expandable cooling chamber
US6585728B2 (en) * 2001-05-25 2003-07-01 Biosense Webster, Inc. Cryoablation catheter with an improved gas expansion chamber
US6634083B1 (en) 1999-01-22 2003-10-21 Seagate Technology Llc Method of forming a magnet/keeper assembly for head level microactuator
US20040002698A1 (en) * 2002-06-26 2004-01-01 Ethicon, Inc. Thermal ablation with deployable cage
US6758831B2 (en) 2001-09-24 2004-07-06 Ethicon, Inc. Device and method for aligning with the tubal ostium
US6813520B2 (en) 1996-04-12 2004-11-02 Novacept Method for ablating and/or coagulating tissue using moisture transport
US20050085880A1 (en) * 1996-04-12 2005-04-21 Csaba Truckai Moisture transport system for contact electrocoagulation
US20050113857A1 (en) * 2000-12-27 2005-05-26 Martin Nohilly Surgical balloon having varying wall thickness
WO2005063136A2 (en) * 2003-12-22 2005-07-14 Ams Research Corporation Cryosurgical devices and methods for endometrial ablation
US20050222650A1 (en) * 2004-04-05 2005-10-06 Seacoast Technologies, Inc. Neurosurgical device for thermally affecting tissue having invertable lumen
US6953469B2 (en) 2001-08-30 2005-10-11 Ethicon, Inc, Device and method for treating intraluminal tissue
US20050251121A1 (en) * 2004-05-10 2005-11-10 Scimed Life Systems, Inc. Probe based low temperature lesion formation apparatus, systems and methods
US20050251122A1 (en) * 2004-05-10 2005-11-10 Scimed Life Systems, Inc. Clamp based low temperature lesion formation apparatus, system and methods
US7083620B2 (en) 2002-10-30 2006-08-01 Medtronic, Inc. Electrosurgical hemostat
US7094235B2 (en) 2001-04-26 2006-08-22 Medtronic, Inc. Method and apparatus for tissue ablation
US7118566B2 (en) 2002-05-16 2006-10-10 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US7128740B2 (en) 1996-05-03 2006-10-31 Jacobs Clemens J Method for interrupting conduction paths within the heart
US20060259029A1 (en) * 1996-10-11 2006-11-16 Utley David S Method for Cryogenic Tissue Ablation
US7156845B2 (en) 1998-07-07 2007-01-02 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US7166105B2 (en) 1995-02-22 2007-01-23 Medtronic, Inc. Pen-type electrosurgical instrument
US7169144B2 (en) 1998-07-07 2007-01-30 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US7250048B2 (en) 2001-04-26 2007-07-31 Medtronic, Inc. Ablation system and method of use
US7291142B2 (en) 2004-05-10 2007-11-06 Boston Scientific Scimed, Inc. Low temperature lesion formation apparatus, systems and methods
US7294143B2 (en) 2002-05-16 2007-11-13 Medtronic, Inc. Device and method for ablation of cardiac tissue
US7309325B2 (en) 1998-07-07 2007-12-18 Medtronic, Inc. Helical needle apparatus for creating a virtual electrode used for the ablation of tissue
US20080015562A1 (en) * 2001-04-26 2008-01-17 Medtronic, Inc. Transmural ablation systems and methods
US7347858B2 (en) 2001-12-11 2008-03-25 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
WO2008046183A1 (en) 2006-10-16 2008-04-24 Cryocath Technologies Inc. Method and apparatus for inflating and deflating balloon catheters
US7364578B2 (en) 2002-01-25 2008-04-29 Medtronic, Inc. System and method of performing an electrosurgical procedure
US7367972B2 (en) 2001-04-26 2008-05-06 Medtronic, Inc. Ablation system
CN100402005C (en) * 2005-12-22 2008-07-16 尹格平 Multifunctional thermal coagulation therapeutic instrument for gynaecologic disease
US7435250B2 (en) 2000-04-27 2008-10-14 Medtronic, Inc. Method and apparatus for tissue ablation
US20080285668A1 (en) * 2005-10-31 2008-11-20 Lee Young-Dae Method for Processing Control Information in a Wireless Mobile Communication System
US7470272B2 (en) 1997-07-18 2008-12-30 Medtronic, Inc. Device and method for ablating tissue
US7497857B2 (en) 2003-04-29 2009-03-03 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US7507235B2 (en) 2001-01-13 2009-03-24 Medtronic, Inc. Method and system for organ positioning and stabilization
US20090088735A1 (en) * 2004-03-23 2009-04-02 Cryocath Technologies Inc. Method and apparatus for inflating and deflating balloon catheters
US20090187181A1 (en) * 1998-05-20 2009-07-23 Shadduck John H Surgical instruments and techniques for treating gastro-esophageal reflux disease
US7566334B2 (en) 2004-06-02 2009-07-28 Medtronic, Inc. Ablation device with jaws
US7615015B2 (en) 2000-01-19 2009-11-10 Medtronic, Inc. Focused ultrasound ablation devices having selectively actuatable emitting elements and methods of using the same
US7628780B2 (en) 2001-01-13 2009-12-08 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US7674260B2 (en) 2005-04-28 2010-03-09 Cytyc Corporation Emergency hemostasis device utilizing energy
US7678108B2 (en) 2004-06-02 2010-03-16 Medtronic, Inc. Loop ablation apparatus and method
WO2010036434A1 (en) * 2008-09-29 2010-04-01 Boston Scientific Scimed, Inc. Fluid recirculation debris handling system
US7706882B2 (en) 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
US7706894B2 (en) 2000-10-10 2010-04-27 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US7727228B2 (en) * 2004-03-23 2010-06-01 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US7731712B2 (en) 2004-12-20 2010-06-08 Cytyc Corporation Method and system for transcervical tubal occlusion
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
EP2198797A1 (en) 2007-08-23 2010-06-23 Aegea Medical, Inc. Uterine therapy device
US7744562B2 (en) 2003-01-14 2010-06-29 Medtronics, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US7758576B2 (en) 2004-06-02 2010-07-20 Medtronic, Inc. Clamping ablation tool and method
US7758580B2 (en) 2004-06-02 2010-07-20 Medtronic, Inc. Compound bipolar ablation device and method
WO2010085460A1 (en) 2009-01-20 2010-07-29 Aegea Medical, Inc. Uterine therapy device and method
US7818039B2 (en) 2000-04-27 2010-10-19 Medtronic, Inc. Suction stabilized epicardial ablation devices
US7824399B2 (en) 2001-04-26 2010-11-02 Medtronic, Inc. Ablation system and method of use
US7846160B2 (en) 2006-12-21 2010-12-07 Cytyc Corporation Method and apparatus for sterilization
US7959627B2 (en) 2005-11-23 2011-06-14 Barrx Medical, Inc. Precision ablating device
US7967816B2 (en) 2002-01-25 2011-06-28 Medtronic, Inc. Fluid-assisted electrosurgical instrument with shapeable electrode
US7993336B2 (en) 1999-11-16 2011-08-09 Barrx Medical, Inc. Methods and systems for determining physiologic characteristics for treatment of the esophagus
US7997278B2 (en) 2005-11-23 2011-08-16 Barrx Medical, Inc. Precision ablating method
US8012149B2 (en) 1999-11-16 2011-09-06 Barrx Medical, Inc. Methods and systems for determining physiologic characteristics for treatment of the esophagus
US8162933B2 (en) 2000-04-27 2012-04-24 Medtronic, Inc. Vibration sensitive ablation device and method
US8192426B2 (en) 2004-01-09 2012-06-05 Tyco Healthcare Group Lp Devices and methods for treatment of luminal tissue
US8221402B2 (en) 2000-01-19 2012-07-17 Medtronic, Inc. Method for guiding a medical device
US8251992B2 (en) 2007-07-06 2012-08-28 Tyco Healthcare Group Lp Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation
US8273012B2 (en) 2007-07-30 2012-09-25 Tyco Healthcare Group, Lp Cleaning device and methods
US8333764B2 (en) 2004-05-12 2012-12-18 Medtronic, Inc. Device and method for determining tissue thickness and creating cardiac ablation lesions
US8398631B2 (en) 1999-11-16 2013-03-19 Covidien Lp System and method of treating abnormal tissue in the human esophagus
US8409219B2 (en) 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
US8439908B2 (en) 2007-07-06 2013-05-14 Covidien Lp Ablation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding
US8486060B2 (en) 2006-09-18 2013-07-16 Cytyc Corporation Power ramping during RF ablation
US8512337B2 (en) 2001-04-26 2013-08-20 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US8551082B2 (en) 1998-05-08 2013-10-08 Cytyc Surgical Products Radio-frequency generator for powering an ablation device
US8568409B2 (en) 2000-03-06 2013-10-29 Medtronic Advanced Energy Llc Fluid-assisted medical devices, systems and methods
US8632533B2 (en) 2009-02-23 2014-01-21 Medtronic Advanced Energy Llc Fluid-assisted electrosurgical device
US20140026395A1 (en) * 2010-05-28 2014-01-30 Medtronic Advanced Energy Llc Fluid-assisted electrosurgical devices, and methods of manufacture thereof
US8641711B2 (en) 2007-05-04 2014-02-04 Covidien Lp Method and apparatus for gastrointestinal tract ablation for treatment of obesity
US8646460B2 (en) 2007-07-30 2014-02-11 Covidien Lp Cleaning device and methods
US8663245B2 (en) 2004-06-18 2014-03-04 Medtronic, Inc. Device for occlusion of a left atrial appendage
US8702695B2 (en) 2005-11-23 2014-04-22 Covidien Lp Auto-aligning ablating device and method of use
US8784338B2 (en) 2007-06-22 2014-07-22 Covidien Lp Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
US8801707B2 (en) 2004-05-14 2014-08-12 Medtronic, Inc. Method and devices for treating atrial fibrillation by mass ablation
US8821488B2 (en) 2008-05-13 2014-09-02 Medtronic, Inc. Tissue lesion evaluation
US8858543B2 (en) 2011-02-01 2014-10-14 Channel Medsystems, Inc. Cyrogenic treatment systems
US8906012B2 (en) 2010-06-30 2014-12-09 Medtronic Advanced Energy Llc Electrosurgical devices with wire electrode
US8926635B2 (en) 2004-06-18 2015-01-06 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
US8945107B2 (en) 2010-10-26 2015-02-03 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9017317B2 (en) 2012-12-06 2015-04-28 Medtronic Ardian Luxembourg S.A.R.L. Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US9138289B2 (en) 2010-06-28 2015-09-22 Medtronic Advanced Energy Llc Electrode sheath for electrosurgical device
US9227088B2 (en) 2006-05-25 2016-01-05 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US9241752B2 (en) 2012-04-27 2016-01-26 Medtronic Ardian Luxembourg S.A.R.L. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods
US9283108B2 (en) 2009-11-26 2016-03-15 Hans I. Wallsten Sterilisation device
US9381061B2 (en) 2000-03-06 2016-07-05 Medtronic Advanced Energy Llc Fluid-assisted medical devices, systems and methods
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9561067B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9662060B2 (en) 2011-10-07 2017-05-30 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
US9700365B2 (en) 2008-10-06 2017-07-11 Santa Anna Tech Llc Method and apparatus for the ablation of gastrointestinal tissue
US9743974B2 (en) 2010-11-09 2017-08-29 Aegea Medical Inc. Positioning method and apparatus for delivering vapor to the uterus
US9895183B2 (en) 2013-09-17 2018-02-20 Channel Medsystems, Inc. Liner for cryogenic treatment systems
US9956029B2 (en) 2014-10-31 2018-05-01 Medtronic Advanced Energy Llc Telescoping device with saline irrigation line
US9974599B2 (en) 2014-08-15 2018-05-22 Medtronic Ps Medical, Inc. Multipurpose electrosurgical device
US9993290B2 (en) 2014-05-22 2018-06-12 Aegea Medical Inc. Systems and methods for performing endometrial ablation
US10004550B2 (en) 2010-08-05 2018-06-26 Medtronic Ardian Luxembourg S.A.R.L. Cryoablation apparatuses, systems, and methods for renal neuromodulation
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US10179019B2 (en) 2014-05-22 2019-01-15 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
US20190083298A1 (en) * 2017-09-21 2019-03-21 Michael W. Starkweather Whole body cryotherapy system
US10278774B2 (en) 2011-03-18 2019-05-07 Covidien Lp Selectively expandable operative element support structure and methods of use
US10335280B2 (en) 2000-01-19 2019-07-02 Medtronic, Inc. Method for ablating target tissue of a patient
US10492842B2 (en) 2014-03-07 2019-12-03 Medtronic Ardian Luxembourg S.A.R.L. Monitoring and controlling internally administered cryotherapy
US20190365453A1 (en) * 2017-02-17 2019-12-05 Boston Scientific Scimed, Inc. System and method for limiting differential pressure across proportional valve during cryoablation procedures
US10588682B2 (en) 2011-04-25 2020-03-17 Medtronic Ardian Luxembourg S.A.R.L. Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
US10610279B2 (en) 2014-04-10 2020-04-07 Channel Medsystems, Inc. Apparatus and methods for regulating cryogenic treatment
US10631914B2 (en) 2013-09-30 2020-04-28 Covidien Lp Bipolar electrosurgical instrument with movable electrode and related systems and methods
US10660697B2 (en) 2009-11-10 2020-05-26 Cardea Medsystems (Tianjin) Co., Ltd. Hollow body cavity ablation apparatus
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US10758303B2 (en) 2009-11-10 2020-09-01 Cardea Medsystems (Tianjin) Co., Ltd. Hollow body cavity ablation apparatus
US10905490B2 (en) 2012-04-27 2021-02-02 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices for renal neuromodulation and associated systems and methods
US11207118B2 (en) 2007-07-06 2021-12-28 Tsunami Medtech, Llc Medical system and method of use
US11284931B2 (en) 2009-02-03 2022-03-29 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
US11331037B2 (en) 2016-02-19 2022-05-17 Aegea Medical Inc. Methods and apparatus for determining the integrity of a bodily cavity
US11413086B2 (en) 2013-03-15 2022-08-16 Tsunami Medtech, Llc Medical system and method of use
US11806066B2 (en) 2018-06-01 2023-11-07 Santa Anna Tech Llc Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US612724A (en) * 1898-10-18 Bert j
US3174481A (en) * 1963-10-14 1965-03-23 Seaman Louis Stomach freezing system with inflatable distributor means
US3460538A (en) * 1967-10-20 1969-08-12 Edward T Armstrong Hypothermia apparatus and method for treating the human body and the like
US3507283A (en) * 1967-10-11 1970-04-21 Univ Northwestern Cryosurgical instrument
US3670732A (en) * 1970-05-11 1972-06-20 Ralph R Robinson Vacuum curette

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US612724A (en) * 1898-10-18 Bert j
US3174481A (en) * 1963-10-14 1965-03-23 Seaman Louis Stomach freezing system with inflatable distributor means
US3507283A (en) * 1967-10-11 1970-04-21 Univ Northwestern Cryosurgical instrument
US3460538A (en) * 1967-10-20 1969-08-12 Edward T Armstrong Hypothermia apparatus and method for treating the human body and the like
US3670732A (en) * 1970-05-11 1972-06-20 Ralph R Robinson Vacuum curette

Cited By (361)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367743A (en) * 1976-05-24 1983-01-11 Virginia M. Gregory Self-pressurizing cryogenic apparatus and method
US4275734A (en) * 1977-08-12 1981-06-30 Valleylab, Inc. Cryosurgical apparatus and method
US4646735A (en) * 1985-10-04 1987-03-03 Seney John S Pain-alleviating tissue treatment assembly
WO1988005646A1 (en) * 1985-10-04 1988-08-11 John Seymour Seney A pain-alleviating tissue treatment assembly
US4865028A (en) * 1987-03-05 1989-09-12 Swart Wilhelmus J B Device for carrying out a therapeutic treatment by means of a refrigerant
US4949718A (en) * 1988-09-09 1990-08-21 Gynelab Products Intrauterine cauterizing apparatus
US5105808A (en) * 1988-09-09 1992-04-21 Gynelab Products Intrauterine cauterizing method
US5108390A (en) * 1988-11-14 1992-04-28 Frigitronics, Inc. Flexible cryoprobe
US5084044A (en) * 1989-07-14 1992-01-28 Ciron Corporation Apparatus for endometrial ablation and method of using same
US5195965A (en) * 1991-03-07 1993-03-23 Shantha Totada R Method and apparatus for localized treatment of human viral infections and cancers
US5451208A (en) * 1991-05-03 1995-09-19 Goldrath; Milton H. Endometrium coagulating apparatus and surgical method for thermal destruction of the endometrium
US5242390A (en) * 1991-05-03 1993-09-07 Goldrath Milton H Endometrium coagulating surgical method for thermal destruction of the endometrium
US5211631A (en) * 1991-07-24 1993-05-18 Sheaff Charles M Patient warming apparatus
US5279598A (en) * 1991-07-24 1994-01-18 Sheaff Charles M Patient warming methods
US5713942A (en) * 1992-05-01 1998-02-03 Vesta Medical, Inc. Body cavity ablation apparatus and model
US6041260A (en) * 1992-05-01 2000-03-21 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5562720A (en) * 1992-05-01 1996-10-08 Vesta Medical, Inc. Bipolar/monopolar endometrial ablation device and method
US5277201A (en) * 1992-05-01 1994-01-11 Vesta Medical, Inc. Endometrial ablation apparatus and method
US5443470A (en) * 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
GB2269107A (en) * 1992-07-31 1994-02-02 Spembly Medical Ltd Cryosurgical ablation
EP0584930A1 (en) * 1992-07-31 1994-03-02 Spembly Medical Limited Cryosurgical ablation
GB2269107B (en) * 1992-07-31 1996-05-08 Spembly Medical Ltd Cryosurgical ablation
US5403309A (en) * 1992-07-31 1995-04-04 Spembly Medical Limited Cryosurgical ablation
US5556377A (en) * 1992-08-12 1996-09-17 Vidamed, Inc. Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5599294A (en) * 1992-08-12 1997-02-04 Vidamed, Inc. Microwave probe device and method
US5895370A (en) * 1992-08-12 1999-04-20 Vidamed, Inc. Medical probe (with stylets) device
US5421819A (en) * 1992-08-12 1995-06-06 Vidamed, Inc. Medical probe device
US5720719A (en) * 1992-08-12 1998-02-24 Vidamed, Inc. Ablative catheter with conformable body
US5720718A (en) * 1992-08-12 1998-02-24 Vidamed, Inc. Medical probe apparatus with enhanced RF, resistance heating, and microwave ablation capabilities
US6022334A (en) * 1992-08-12 2000-02-08 Vidamed, Inc. Medical probe device with optic viewing capability
US5470308A (en) * 1992-08-12 1995-11-28 Vidamed, Inc. Medical probe with biopsy stylet
US5470309A (en) * 1992-08-12 1995-11-28 Vidamed, Inc. Medical ablation apparatus utilizing a heated stylet
US5366490A (en) * 1992-08-12 1994-11-22 Vidamed, Inc. Medical probe device and method
US5409453A (en) * 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
US5514131A (en) * 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5385544A (en) * 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US5672153A (en) * 1992-08-12 1997-09-30 Vidamed, Inc. Medical probe device and method
US5630794A (en) * 1992-08-12 1997-05-20 Vidamed, Inc. Catheter tip and method of manufacturing
US5607389A (en) * 1992-08-12 1997-03-04 Vidamed, Inc. Medical probe with biopsy stylet
US5542915A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US5554110A (en) * 1992-08-12 1996-09-10 Vidamed, Inc. Medical ablation apparatus
US5435805A (en) * 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US6464661B2 (en) 1992-08-12 2002-10-15 Vidamed, Inc. Medical probe with stylets
US5370675A (en) * 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US6206847B1 (en) 1992-08-12 2001-03-27 Vidamed, Inc. Medical probe device
US5599295A (en) * 1992-08-12 1997-02-04 Vidamed, Inc. Medical probe apparatus with enhanced RF, resistance heating, and microwave ablation capabilities
US5540679A (en) * 1992-10-05 1996-07-30 Boston Scientific Corporation Device and method for heating tissue in a patient's body
US5702435A (en) * 1993-01-25 1997-12-30 State Of Israel Ministry Of Defense, Rafael-Armaments Fast changing heating-cooling device and method
US5891188A (en) * 1993-01-25 1999-04-06 State Of Israel, Ministry Of Defense, Rafael-Armaments Development Authority Fast changing heating-cooling device and method
US5522870A (en) * 1993-01-25 1996-06-04 State Of Israel, Ministry Of Defense, Rafael-Armaments Development Authority Fast changing heating-cooling device and method
US5456662A (en) * 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US6161543A (en) * 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
EP0624347A1 (en) * 1993-05-10 1994-11-17 Browning Healthcare Limited Cryoprobe
US5449380A (en) * 1993-09-17 1995-09-12 Origin Medsystems, Inc. Apparatus and method for organ ablation
US5540062A (en) * 1993-11-01 1996-07-30 State Of Israel, Ministry Of Defence, Rafael Armaments Development Authority Controlled cryogenic contact system
US5577387A (en) * 1993-11-01 1996-11-26 State Of Israel, Ministry Of Defence, Rafael-Armaments Development Authority Controlled cryogenic contact system
US5501681A (en) * 1993-11-12 1996-03-26 Neuwirth; Robert S. Intrauterine cryoablation cauterizing apparatus and method
WO1995013026A1 (en) * 1993-11-12 1995-05-18 Neuwirth Robert S Intrauterine cryoablation cauterizing apparatus and method
US5437629A (en) * 1994-04-14 1995-08-01 Bei Medical Systems Fluid delivery system for hysteroscopic endometrial ablation
US5769846A (en) * 1994-06-24 1998-06-23 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5569241A (en) * 1994-06-24 1996-10-29 Vidacare, Inc. Thin layer ablation apparatus
US5827273A (en) * 1994-06-24 1998-10-27 Stuart D. Edwards Thin layer ablation apparatus
US5558672A (en) * 1994-06-24 1996-09-24 Vidacare, Inc. Thin layer ablation apparatus
US5575788A (en) * 1994-06-24 1996-11-19 Stuart D. Edwards Thin layer ablation apparatus
US5681308A (en) * 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5693077A (en) * 1994-09-21 1997-12-02 Friedman; Mark H. Treatment of vascular and tension headache atypical facial pain allergic rhinitis and cervical muscle hyperactivity
US5957917A (en) * 1995-01-20 1999-09-28 Miravant Systems, Inc. Transluminal hyperthermia catheter and method for use
US7794460B2 (en) 1995-02-22 2010-09-14 Medtronic, Inc. Method of ablating tissue
US9770282B2 (en) 1995-02-22 2017-09-26 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US7422588B2 (en) 1995-02-22 2008-09-09 Medtronic, Inc. Pen-type electrosurgical instrument
US7166105B2 (en) 1995-02-22 2007-01-23 Medtronic, Inc. Pen-type electrosurgical instrument
US7247155B2 (en) 1995-02-22 2007-07-24 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6224591B1 (en) 1995-03-01 2001-05-01 Atos Medical Ab Device and method for hyperthermia treatment
US5800493A (en) * 1995-04-26 1998-09-01 Gynecare, Inc. Intrauterine ablation system
US6197351B1 (en) 1995-06-07 2001-03-06 Robert S. Neuwirth Intrauterine chemical necrosing method and composition
US6187346B1 (en) 1995-06-07 2001-02-13 Ablation Products, Inc. Intrauterine chemical cauterizing method and composition
US6530234B1 (en) 1995-10-12 2003-03-11 Cryogen, Inc. Precooling system for Joule-Thomson probe
US7604633B2 (en) 1996-04-12 2009-10-20 Cytyc Corporation Moisture transport system for contact electrocoagulation
US7512445B2 (en) 1996-04-12 2009-03-31 Cytyc Corporation Moisture transport system for contact electrocoagulation
US20050267468A1 (en) * 1996-04-12 2005-12-01 Csaba Truckai Moisture transport system for contact electrocoagulation
US5769880A (en) * 1996-04-12 1998-06-23 Novacept Moisture transport system for contact electrocoagulation
US20050085880A1 (en) * 1996-04-12 2005-04-21 Csaba Truckai Moisture transport system for contact electrocoagulation
US8506563B2 (en) 1996-04-12 2013-08-13 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US6813520B2 (en) 1996-04-12 2004-11-02 Novacept Method for ablating and/or coagulating tissue using moisture transport
US9247989B2 (en) 1996-04-12 2016-02-02 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US9095348B2 (en) 1996-04-12 2015-08-04 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US8998898B2 (en) 1996-04-12 2015-04-07 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US7128740B2 (en) 1996-05-03 2006-10-31 Jacobs Clemens J Method for interrupting conduction paths within the heart
US7632268B2 (en) 1996-10-11 2009-12-15 BÂRRX Medical, Inc. System for tissue ablation
US20060259029A1 (en) * 1996-10-11 2006-11-16 Utley David S Method for Cryogenic Tissue Ablation
US7507234B2 (en) 1996-10-11 2009-03-24 BÂRRX Medical, Inc. Method for cryogenic tissue ablation
US7556628B2 (en) 1996-10-11 2009-07-07 BÂRRX Medical, Inc. Method for tissue ablation
US6451012B2 (en) 1996-12-26 2002-09-17 Cryogen, Inc. Cryosurgical method for endometrial ablation
US6270494B1 (en) 1996-12-26 2001-08-07 Cryogen, Inc. Stretchable cryoprobe sheath
US6475212B2 (en) 1996-12-26 2002-11-05 Cryogen, Inc. Cryosurgical probe with sheath
US6182666B1 (en) 1996-12-26 2001-02-06 Cryogen, Inc. Cryosurgical probe and method for uterine ablation
US6193644B1 (en) 1996-12-26 2001-02-27 Cryogen, Inc. Cryosurgical probe with sheath
WO1998046148A1 (en) * 1997-04-14 1998-10-22 The Johns Hopkins University Endoscopic cryospray device
US5846235A (en) * 1997-04-14 1998-12-08 Johns Hopkins University Endoscopic cryospray device
US6165492A (en) * 1997-05-12 2000-12-26 Neuwirth; Robert S. Intrauterine chemical necrosing method, composition, and apparatus
US5891457A (en) * 1997-05-12 1999-04-06 Neuwirth; Robert S. Intrauterine chemical necrosing method, composition, and apparatus
US6027499A (en) * 1997-05-23 2000-02-22 Fiber-Tech Medical, Inc. (Assignee Of Jennifer B. Cartledge) Method and apparatus for cryogenic spray ablation of gastrointestinal mucosa
US7678111B2 (en) 1997-07-18 2010-03-16 Medtronic, Inc. Device and method for ablating tissue
US7470272B2 (en) 1997-07-18 2008-12-30 Medtronic, Inc. Device and method for ablating tissue
US6306129B1 (en) 1997-09-22 2001-10-23 Femrx, Inc. Cryosurgical system and method
US7507238B2 (en) 1998-02-19 2009-03-24 Barrx Medical, Inc Method for vacuum-assisted tissue ablation
US9554853B2 (en) 1998-05-08 2017-01-31 Hologic, Inc. Radio-frequency generator for powering an ablation device
US8551082B2 (en) 1998-05-08 2013-10-08 Cytyc Surgical Products Radio-frequency generator for powering an ablation device
US20090187181A1 (en) * 1998-05-20 2009-07-23 Shadduck John H Surgical instruments and techniques for treating gastro-esophageal reflux disease
WO1999060960A1 (en) * 1998-05-22 1999-12-02 James Elliott Endometrial ablation method and apparatus
US6066132A (en) * 1998-06-30 2000-05-23 Ethicon, Inc. Articulating endometrial ablation device
US7699805B2 (en) 1998-07-07 2010-04-20 Medtronic, Inc. Helical coil apparatus for ablation of tissue
US9113896B2 (en) 1998-07-07 2015-08-25 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US7309325B2 (en) 1998-07-07 2007-12-18 Medtronic, Inc. Helical needle apparatus for creating a virtual electrode used for the ablation of tissue
US7156845B2 (en) 1998-07-07 2007-01-02 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US7169144B2 (en) 1998-07-07 2007-01-30 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6634083B1 (en) 1999-01-22 2003-10-21 Seagate Technology Llc Method of forming a magnet/keeper assembly for head level microactuator
US9597147B2 (en) 1999-11-16 2017-03-21 Covidien Lp Methods and systems for treatment of tissue in a body lumen
US9039699B2 (en) 1999-11-16 2015-05-26 Covidien Lp Methods and systems for treatment of tissue in a body lumen
US8398631B2 (en) 1999-11-16 2013-03-19 Covidien Lp System and method of treating abnormal tissue in the human esophagus
US8377055B2 (en) 1999-11-16 2013-02-19 Covidien Lp Methods and systems for determining physiologic characteristics for treatment of the esophagus
US7993336B2 (en) 1999-11-16 2011-08-09 Barrx Medical, Inc. Methods and systems for determining physiologic characteristics for treatment of the esophagus
US8012149B2 (en) 1999-11-16 2011-09-06 Barrx Medical, Inc. Methods and systems for determining physiologic characteristics for treatment of the esophagus
US8876818B2 (en) 1999-11-16 2014-11-04 Covidien Lp Methods and systems for determining physiologic characteristics for treatment of the esophagus
US9555222B2 (en) 1999-11-16 2017-01-31 Covidien Lp Methods and systems for determining physiologic characteristics for treatment of the esophagus
US8221402B2 (en) 2000-01-19 2012-07-17 Medtronic, Inc. Method for guiding a medical device
US10335280B2 (en) 2000-01-19 2019-07-02 Medtronic, Inc. Method for ablating target tissue of a patient
US7706882B2 (en) 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
US7615015B2 (en) 2000-01-19 2009-11-10 Medtronic, Inc. Focused ultrasound ablation devices having selectively actuatable emitting elements and methods of using the same
US6551274B2 (en) 2000-02-29 2003-04-22 Biosense Webster, Inc. Cryoablation catheter with an expandable cooling chamber
US6443947B1 (en) 2000-03-01 2002-09-03 Alexei Marko Device for thermal ablation of a cavity
JP2003524498A (en) * 2000-03-01 2003-08-19 サーマル アブレイション テクノロジーズ カナダ リミテッド Device for thermal ablation of body cavity
US7419500B2 (en) 2000-03-01 2008-09-02 Idoman Limited Device for thermal ablation of a cavity
US8568409B2 (en) 2000-03-06 2013-10-29 Medtronic Advanced Energy Llc Fluid-assisted medical devices, systems and methods
US9381061B2 (en) 2000-03-06 2016-07-05 Medtronic Advanced Energy Llc Fluid-assisted medical devices, systems and methods
US7818039B2 (en) 2000-04-27 2010-10-19 Medtronic, Inc. Suction stabilized epicardial ablation devices
US7435250B2 (en) 2000-04-27 2008-10-14 Medtronic, Inc. Method and apparatus for tissue ablation
US8162933B2 (en) 2000-04-27 2012-04-24 Medtronic, Inc. Vibration sensitive ablation device and method
US9693819B2 (en) 2000-04-27 2017-07-04 Medtronic, Inc. Vibration sensitive ablation device and method
US6395012B1 (en) * 2000-05-04 2002-05-28 Inbae Yoon Apparatus and method for delivering and deploying an expandable body member in a uterine cavity
US6547784B1 (en) * 2000-06-23 2003-04-15 Ethicon, Inc. System and method for placement of a surgical instrument in a body cavity
US7706894B2 (en) 2000-10-10 2010-04-27 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US8706260B2 (en) 2000-10-10 2014-04-22 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US20050113857A1 (en) * 2000-12-27 2005-05-26 Martin Nohilly Surgical balloon having varying wall thickness
US6951569B2 (en) 2000-12-27 2005-10-04 Ethicon, Inc. Surgical balloon having varying wall thickness
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US7507235B2 (en) 2001-01-13 2009-03-24 Medtronic, Inc. Method and system for organ positioning and stabilization
US7628780B2 (en) 2001-01-13 2009-12-08 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US7250051B2 (en) 2001-04-26 2007-07-31 Medtronic, Inc. Method and apparatus for tissue ablation
US7250048B2 (en) 2001-04-26 2007-07-31 Medtronic, Inc. Ablation system and method of use
US8221415B2 (en) 2001-04-26 2012-07-17 Medtronic, Inc. Method and apparatus for tissue ablation
US7959626B2 (en) 2001-04-26 2011-06-14 Medtronic, Inc. Transmural ablation systems and methods
US20080015562A1 (en) * 2001-04-26 2008-01-17 Medtronic, Inc. Transmural ablation systems and methods
US7367972B2 (en) 2001-04-26 2008-05-06 Medtronic, Inc. Ablation system
US7824399B2 (en) 2001-04-26 2010-11-02 Medtronic, Inc. Ablation system and method of use
US8262649B2 (en) 2001-04-26 2012-09-11 Medtronic, Inc. Method and apparatus for tissue ablation
US7094235B2 (en) 2001-04-26 2006-08-22 Medtronic, Inc. Method and apparatus for tissue ablation
US8512337B2 (en) 2001-04-26 2013-08-20 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US6585728B2 (en) * 2001-05-25 2003-07-01 Biosense Webster, Inc. Cryoablation catheter with an improved gas expansion chamber
US6953469B2 (en) 2001-08-30 2005-10-11 Ethicon, Inc, Device and method for treating intraluminal tissue
US6758831B2 (en) 2001-09-24 2004-07-06 Ethicon, Inc. Device and method for aligning with the tubal ostium
US7347858B2 (en) 2001-12-11 2008-03-25 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US8623010B2 (en) 2002-01-25 2014-01-07 Medtronic, Inc. Cardiac mapping instrument with shapeable electrode
US7364578B2 (en) 2002-01-25 2008-04-29 Medtronic, Inc. System and method of performing an electrosurgical procedure
US7967816B2 (en) 2002-01-25 2011-06-28 Medtronic, Inc. Fluid-assisted electrosurgical instrument with shapeable electrode
US7975703B2 (en) 2002-05-16 2011-07-12 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US8414573B2 (en) 2002-05-16 2013-04-09 Medtronic, Inc. Device and method for ablation of cardiac tissue
US7294143B2 (en) 2002-05-16 2007-11-13 Medtronic, Inc. Device and method for ablation of cardiac tissue
US7118566B2 (en) 2002-05-16 2006-10-10 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US20040002698A1 (en) * 2002-06-26 2004-01-01 Ethicon, Inc. Thermal ablation with deployable cage
US6960203B2 (en) 2002-06-26 2005-11-01 Ethicon, Inc. Thermal ablation with deployable cage
US7963963B2 (en) 2002-10-30 2011-06-21 Medtronic, Inc. Electrosurgical hemostat
US7083620B2 (en) 2002-10-30 2006-08-01 Medtronic, Inc. Electrosurgical hemostat
US7744562B2 (en) 2003-01-14 2010-06-29 Medtronics, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US8273072B2 (en) 2003-01-14 2012-09-25 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US7871409B2 (en) 2003-04-29 2011-01-18 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US7497857B2 (en) 2003-04-29 2009-03-03 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US7381208B2 (en) 2003-12-22 2008-06-03 Ams Research Corporation Cryosurgical devices for endometrial ablation
US7500973B2 (en) 2003-12-22 2009-03-10 Ams Research Corporation Cryosurgical devices and methods for endometrial ablation
US20090138000A1 (en) * 2003-12-22 2009-05-28 Vancelette David W Cryosurgical devices and methods for endometrial ablation
WO2005063136A2 (en) * 2003-12-22 2005-07-14 Ams Research Corporation Cryosurgical devices and methods for endometrial ablation
AU2004308416B2 (en) * 2003-12-22 2010-03-18 Ams Research Corporation Cryosurgical devices and methods for endometrial ablation
WO2005063136A3 (en) * 2003-12-22 2005-08-25 Ams Res Corp Cryosurgical devices and methods for endometrial ablation
US10856939B2 (en) 2004-01-09 2020-12-08 Covidien Lp Devices and methods for treatment of luminal tissue
US9393069B2 (en) 2004-01-09 2016-07-19 Covidien Lp Devices and methods for treatment of luminal tissue
US10278776B2 (en) 2004-01-09 2019-05-07 Covidien Lp Devices and methods for treatment of luminal tissue
US8192426B2 (en) 2004-01-09 2012-06-05 Tyco Healthcare Group Lp Devices and methods for treatment of luminal tissue
US8545491B2 (en) * 2004-03-23 2013-10-01 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US9808301B2 (en) 2004-03-23 2017-11-07 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US8491636B2 (en) * 2004-03-23 2013-07-23 Medtronic Cryopath LP Method and apparatus for inflating and deflating balloon catheters
US8900222B2 (en) 2004-03-23 2014-12-02 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US8382747B2 (en) 2004-03-23 2013-02-26 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US11357563B2 (en) * 2004-03-23 2022-06-14 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US20090088735A1 (en) * 2004-03-23 2009-04-02 Cryocath Technologies Inc. Method and apparatus for inflating and deflating balloon catheters
US7727228B2 (en) * 2004-03-23 2010-06-01 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US9555223B2 (en) 2004-03-23 2017-01-31 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US20050222650A1 (en) * 2004-04-05 2005-10-06 Seacoast Technologies, Inc. Neurosurgical device for thermally affecting tissue having invertable lumen
US7291143B2 (en) 2004-05-10 2007-11-06 Boston Scientific Scimed, Inc. Clamp based low temperature lesion formation apparatus, systems and methods
US20050251122A1 (en) * 2004-05-10 2005-11-10 Scimed Life Systems, Inc. Clamp based low temperature lesion formation apparatus, system and methods
US20050251121A1 (en) * 2004-05-10 2005-11-10 Scimed Life Systems, Inc. Probe based low temperature lesion formation apparatus, systems and methods
US7972327B2 (en) 2004-05-10 2011-07-05 Boston Scientific Scimed, Inc. Low temperature lesion formation apparatus, systems and methods
US7291142B2 (en) 2004-05-10 2007-11-06 Boston Scientific Scimed, Inc. Low temperature lesion formation apparatus, systems and methods
US7861725B2 (en) 2004-05-10 2011-01-04 Boston Scientific Scimed, Inc. Method for monitoring formation of a lesion in a tissue structure using a cryogenic system
US20080058791A1 (en) * 2004-05-10 2008-03-06 Boston Scientific Scimed, Inc. Low temperature lesion formation apparatus, systems and methods
US7582083B2 (en) * 2004-05-10 2009-09-01 Boston Scientific Scimed, Inc. Probe based low temperature lesion formation apparatus, systems and methods
US20060167444A1 (en) * 2004-05-10 2006-07-27 Swanson David K Clamp Based Low Temperature Lesion Formation Apparatus, Systems And Methods
US20080058790A1 (en) * 2004-05-10 2008-03-06 Boston Scientific Scimed, Inc. Clamp based low temperature lesion formation apparatus, systems and methods
US20070219545A1 (en) * 2004-05-10 2007-09-20 Boston Scientific Scimed Inc. Probe based low temperature lesion formation apparatus, systems and methods
US7288088B2 (en) * 2004-05-10 2007-10-30 Boston Scientific Scimed, Inc. Clamp based low temperature lesion formation apparatus, systems and methods
US8142424B2 (en) * 2004-05-10 2012-03-27 Boston Scientific Scimed, Inc. Probe based low temperature lesion formation apparatus, systems and methods
US8333764B2 (en) 2004-05-12 2012-12-18 Medtronic, Inc. Device and method for determining tissue thickness and creating cardiac ablation lesions
US8801707B2 (en) 2004-05-14 2014-08-12 Medtronic, Inc. Method and devices for treating atrial fibrillation by mass ablation
US7875028B2 (en) 2004-06-02 2011-01-25 Medtronic, Inc. Ablation device with jaws
US20090270857A1 (en) * 2004-06-02 2009-10-29 Christian Steven C Ablation Device with Jaws
US8162941B2 (en) 2004-06-02 2012-04-24 Medtronic, Inc. Ablation device with jaws
US7566334B2 (en) 2004-06-02 2009-07-28 Medtronic, Inc. Ablation device with jaws
US7678108B2 (en) 2004-06-02 2010-03-16 Medtronic, Inc. Loop ablation apparatus and method
US7758580B2 (en) 2004-06-02 2010-07-20 Medtronic, Inc. Compound bipolar ablation device and method
US7758576B2 (en) 2004-06-02 2010-07-20 Medtronic, Inc. Clamping ablation tool and method
US8172837B2 (en) 2004-06-02 2012-05-08 Medtronic, Inc. Clamping ablation tool and method
US9656063B2 (en) 2004-06-18 2017-05-23 Medtronic, Inc. Method and system for placement of electrical lead inside heart
US8409219B2 (en) 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
US8926635B2 (en) 2004-06-18 2015-01-06 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
US8663245B2 (en) 2004-06-18 2014-03-04 Medtronic, Inc. Device for occlusion of a left atrial appendage
US7731712B2 (en) 2004-12-20 2010-06-08 Cytyc Corporation Method and system for transcervical tubal occlusion
US7674260B2 (en) 2005-04-28 2010-03-09 Cytyc Corporation Emergency hemostasis device utilizing energy
US20080285668A1 (en) * 2005-10-31 2008-11-20 Lee Young-Dae Method for Processing Control Information in a Wireless Mobile Communication System
US7959627B2 (en) 2005-11-23 2011-06-14 Barrx Medical, Inc. Precision ablating device
US7997278B2 (en) 2005-11-23 2011-08-16 Barrx Medical, Inc. Precision ablating method
US8702694B2 (en) 2005-11-23 2014-04-22 Covidien Lp Auto-aligning ablating device and method of use
US9179970B2 (en) 2005-11-23 2015-11-10 Covidien Lp Precision ablating method
US9918793B2 (en) 2005-11-23 2018-03-20 Covidien Lp Auto-aligning ablating device and method of use
US8702695B2 (en) 2005-11-23 2014-04-22 Covidien Lp Auto-aligning ablating device and method of use
US9918794B2 (en) 2005-11-23 2018-03-20 Covidien Lp Auto-aligning ablating device and method of use
CN100402005C (en) * 2005-12-22 2008-07-16 尹格平 Multifunctional thermal coagulation therapeutic instrument for gynaecologic disease
US9724119B2 (en) 2006-05-25 2017-08-08 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US9931134B2 (en) 2006-05-25 2018-04-03 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US9227088B2 (en) 2006-05-25 2016-01-05 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US10589130B2 (en) 2006-05-25 2020-03-17 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US8486060B2 (en) 2006-09-18 2013-07-16 Cytyc Corporation Power ramping during RF ablation
EP2081511A1 (en) * 2006-10-16 2009-07-29 Cryocath Technologies inc. Method and apparatus for inflating and deflating balloon catheters
WO2008046183A1 (en) 2006-10-16 2008-04-24 Cryocath Technologies Inc. Method and apparatus for inflating and deflating balloon catheters
EP2081511A4 (en) * 2006-10-16 2011-06-08 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US7846160B2 (en) 2006-12-21 2010-12-07 Cytyc Corporation Method and apparatus for sterilization
US8641711B2 (en) 2007-05-04 2014-02-04 Covidien Lp Method and apparatus for gastrointestinal tract ablation for treatment of obesity
US9993281B2 (en) 2007-05-04 2018-06-12 Covidien Lp Method and apparatus for gastrointestinal tract ablation for treatment of obesity
US10575902B2 (en) 2007-06-22 2020-03-03 Covidien Lp Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
US8784338B2 (en) 2007-06-22 2014-07-22 Covidien Lp Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
US9198713B2 (en) 2007-06-22 2015-12-01 Covidien Lp Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
US9839466B2 (en) 2007-07-06 2017-12-12 Covidien Lp Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation
US8439908B2 (en) 2007-07-06 2013-05-14 Covidien Lp Ablation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding
US8251992B2 (en) 2007-07-06 2012-08-28 Tyco Healthcare Group Lp Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation
US9364283B2 (en) 2007-07-06 2016-06-14 Covidien Lp Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation
US11207118B2 (en) 2007-07-06 2021-12-28 Tsunami Medtech, Llc Medical system and method of use
US9314289B2 (en) 2007-07-30 2016-04-19 Covidien Lp Cleaning device and methods
US8646460B2 (en) 2007-07-30 2014-02-11 Covidien Lp Cleaning device and methods
US8273012B2 (en) 2007-07-30 2012-09-25 Tyco Healthcare Group, Lp Cleaning device and methods
US8221403B2 (en) 2007-08-23 2012-07-17 Aegea Medical, Inc. Uterine therapy device and method
US20190117290A1 (en) * 2007-08-23 2019-04-25 Aegea Medical Inc. Uterine therapy device and method
US11213338B2 (en) * 2007-08-23 2022-01-04 Aegea Medical Inc. Uterine therapy device and method
US8197470B2 (en) 2007-08-23 2012-06-12 Aegea Medical, Inc. Uterine therapy device and method
US8216217B2 (en) 2007-08-23 2012-07-10 Aegea Medical, Inc. Uterine therapy device and method
US10758292B2 (en) * 2007-08-23 2020-09-01 Aegea Medical Inc. Uterine therapy device and method
US8221401B2 (en) 2007-08-23 2012-07-17 Aegea Medical, Inc. Uterine therapy device and method
EP2522290A2 (en) 2007-08-23 2012-11-14 Aegea Medical, Inc. Uterine therapy device
US10154871B2 (en) 2007-08-23 2018-12-18 Aegea Medical Inc. Uterine therapy device and method
EP2198797A1 (en) 2007-08-23 2010-06-23 Aegea Medical, Inc. Uterine therapy device
US20190117289A1 (en) * 2007-08-23 2019-04-25 Aegea Medical Inc. Uterine therapy device and method
US8821488B2 (en) 2008-05-13 2014-09-02 Medtronic, Inc. Tissue lesion evaluation
US8790334B2 (en) 2008-09-29 2014-07-29 Boston Scientific Scimed, Inc. Fluid recirculation debris handling system
WO2010036434A1 (en) * 2008-09-29 2010-04-01 Boston Scientific Scimed, Inc. Fluid recirculation debris handling system
US9700365B2 (en) 2008-10-06 2017-07-11 Santa Anna Tech Llc Method and apparatus for the ablation of gastrointestinal tissue
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US11813014B2 (en) 2008-10-06 2023-11-14 Santa Anna Tech Llc Methods and systems for directed tissue ablation
US11779430B2 (en) 2008-10-06 2023-10-10 Santa Anna Tech Llc Vapor based ablation system for treating uterine bleeding
US11589920B2 (en) 2008-10-06 2023-02-28 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply an ablative zone to tissue
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9561067B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US10842557B2 (en) 2008-10-06 2020-11-24 Santa Anna Tech Llc Vapor ablation system with a catheter having more than one positioning element and configured to treat duodenal tissue
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US10842549B2 (en) 2008-10-06 2020-11-24 Santa Anna Tech Llc Vapor ablation system with a catheter having more than one positioning element and configured to treat pulmonary tissue
US11020175B2 (en) 2008-10-06 2021-06-01 Santa Anna Tech Llc Methods of ablating tissue using time-limited treatment periods
US10842548B2 (en) 2008-10-06 2020-11-24 Santa Anna Tech Llc Vapor ablation system with a catheter having more than one positioning element
WO2010085460A1 (en) 2009-01-20 2010-07-29 Aegea Medical, Inc. Uterine therapy device and method
CN102355864A (en) * 2009-01-20 2012-02-15 埃杰亚医疗公司 Uterine therapy device and method
US11284931B2 (en) 2009-02-03 2022-03-29 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
US8632533B2 (en) 2009-02-23 2014-01-21 Medtronic Advanced Energy Llc Fluid-assisted electrosurgical device
US9486283B2 (en) 2009-02-23 2016-11-08 Medtronic Advanced Energy Llc Fluid-assisted electrosurgical device
US10660697B2 (en) 2009-11-10 2020-05-26 Cardea Medsystems (Tianjin) Co., Ltd. Hollow body cavity ablation apparatus
US10758303B2 (en) 2009-11-10 2020-09-01 Cardea Medsystems (Tianjin) Co., Ltd. Hollow body cavity ablation apparatus
US9283108B2 (en) 2009-11-26 2016-03-15 Hans I. Wallsten Sterilisation device
US20140026395A1 (en) * 2010-05-28 2014-01-30 Medtronic Advanced Energy Llc Fluid-assisted electrosurgical devices, and methods of manufacture thereof
US9333027B2 (en) * 2010-05-28 2016-05-10 Medtronic Advanced Energy Llc Method of producing an electrosurgical device
US9138289B2 (en) 2010-06-28 2015-09-22 Medtronic Advanced Energy Llc Electrode sheath for electrosurgical device
US9895191B2 (en) 2010-06-28 2018-02-20 Medtronic Advanced Energy Llc Electrode sheath for electrosurgical device
US8906012B2 (en) 2010-06-30 2014-12-09 Medtronic Advanced Energy Llc Electrosurgical devices with wire electrode
US10004550B2 (en) 2010-08-05 2018-06-26 Medtronic Ardian Luxembourg S.A.R.L. Cryoablation apparatuses, systems, and methods for renal neuromodulation
US11457969B2 (en) 2010-08-13 2022-10-04 Tsunami Medtech, Llc Medical system and method of use
US9066713B2 (en) 2010-10-26 2015-06-30 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US10842547B2 (en) 2010-10-26 2020-11-24 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US8945107B2 (en) 2010-10-26 2015-02-03 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9060755B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9439708B2 (en) 2010-10-26 2016-09-13 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US10188445B2 (en) 2010-10-26 2019-01-29 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US11160597B2 (en) 2010-11-09 2021-11-02 Aegea Medical Inc. Positioning method and apparatus for delivering vapor to the uterus
US9743974B2 (en) 2010-11-09 2017-08-29 Aegea Medical Inc. Positioning method and apparatus for delivering vapor to the uterus
US10238446B2 (en) 2010-11-09 2019-03-26 Aegea Medical Inc. Positioning method and apparatus for delivering vapor to the uterus
US9517100B2 (en) 2011-02-01 2016-12-13 Channel Medsystems, Inc. Cryogenic treatment methods
US9486267B2 (en) 2011-02-01 2016-11-08 Channel Medsystems, Inc. Cryogenic treatment systems
US11833076B2 (en) 2011-02-01 2023-12-05 Channel Medsystems, Inc. Methods and apparatus for cryogenic treatment of a body cavity or lumen
US9283022B2 (en) 2011-02-01 2016-03-15 Channel Medsystems, Inc. Methods and apparatus for cryogenic treatment of a body cavity or lumen
US9510887B2 (en) 2011-02-01 2016-12-06 Channel Medsystems, Inc. Time-limited methods for cryogenic treatment systems
US9498274B2 (en) 2011-02-01 2016-11-22 Channel Medsystems, Inc. Liner extraction methods
US9492217B2 (en) 2011-02-01 2016-11-15 Channel Medsystems, Inc. Treatments using cryogenic ablation systems
US9492218B2 (en) 2011-02-01 2016-11-15 Channel Medsystems, Inc. Pressure monitoring systems
US9603650B2 (en) 2011-02-01 2017-03-28 Channel Medsystems, Inc. Cryogenic treatment systems
US9848933B2 (en) 2011-02-01 2017-12-26 Channel Medsystems, Inc. Liner for cryogenic treatment systems
US11883324B2 (en) * 2011-02-01 2024-01-30 Channel Medsystems, Inc. Cryogenic treatment systems
US10213335B2 (en) 2011-02-01 2019-02-26 Channel Medsystems, Inc. Methods and apparatus for cryogenic treatment of a body cavity or lumen
US8858543B2 (en) 2011-02-01 2014-10-14 Channel Medsystems, Inc. Cyrogenic treatment systems
US9408657B2 (en) 2011-02-01 2016-08-09 Channel Medsystems, Inc. Cryogenic treatment systems
US9445860B2 (en) 2011-02-01 2016-09-20 Channel Medsystems, Inc. Handheld cyrogenic treatment systems
US10959879B2 (en) 2011-02-01 2021-03-30 Channel Medsystems, Inc. Methods and apparatus for cryogenic treatment of a body cavity or lumen
US9277952B2 (en) 2011-02-01 2016-03-08 Channel Medsystems, Inc. Cryogenic treatment systems
US10278774B2 (en) 2011-03-18 2019-05-07 Covidien Lp Selectively expandable operative element support structure and methods of use
US10588682B2 (en) 2011-04-25 2020-03-17 Medtronic Ardian Luxembourg S.A.R.L. Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
US10881442B2 (en) 2011-10-07 2021-01-05 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
US9662060B2 (en) 2011-10-07 2017-05-30 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
US9241752B2 (en) 2012-04-27 2016-01-26 Medtronic Ardian Luxembourg S.A.R.L. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods
US11751931B2 (en) 2012-04-27 2023-09-12 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices for renal neuromodulation and associated systems and methods
US9872718B2 (en) 2012-04-27 2018-01-23 Medtronic Adrian Luxembourg S.a.r.l. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods
US10905490B2 (en) 2012-04-27 2021-02-02 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices for renal neuromodulation and associated systems and methods
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US9017317B2 (en) 2012-12-06 2015-04-28 Medtronic Ardian Luxembourg S.A.R.L. Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods
US11413086B2 (en) 2013-03-15 2022-08-16 Tsunami Medtech, Llc Medical system and method of use
US11672584B2 (en) 2013-03-15 2023-06-13 Tsunami Medtech, Llc Medical system and method of use
US9895183B2 (en) 2013-09-17 2018-02-20 Channel Medsystems, Inc. Liner for cryogenic treatment systems
US11607263B2 (en) 2013-09-17 2023-03-21 Channel Medsystems, Inc. Liner for cryogenic treatment systems
US10849672B2 (en) 2013-09-17 2020-12-01 Channel Medsystems, Inc. Liner for cryogenic treatment systems
US10631914B2 (en) 2013-09-30 2020-04-28 Covidien Lp Bipolar electrosurgical instrument with movable electrode and related systems and methods
US11241272B2 (en) 2013-09-30 2022-02-08 Covidien Lp Bipolar electrosurgical instrument with movable electrode and related systems and methods
US10492842B2 (en) 2014-03-07 2019-12-03 Medtronic Ardian Luxembourg S.A.R.L. Monitoring and controlling internally administered cryotherapy
US11406437B2 (en) 2014-03-07 2022-08-09 Medtronic Ardian Luxembourg S.A.R.L. Monitoring and controlling internally administered cryotherapy
US10610279B2 (en) 2014-04-10 2020-04-07 Channel Medsystems, Inc. Apparatus and methods for regulating cryogenic treatment
US11793561B2 (en) 2014-04-10 2023-10-24 Channel Medsystems, Inc. Apparatus and methods for regulating cryogenic treatment
US10575898B2 (en) 2014-05-22 2020-03-03 Aegea Medical Inc. Systems and methods for performing endometrial ablation
US9993290B2 (en) 2014-05-22 2018-06-12 Aegea Medical Inc. Systems and methods for performing endometrial ablation
US11219479B2 (en) 2014-05-22 2022-01-11 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
US10299856B2 (en) 2014-05-22 2019-05-28 Aegea Medical Inc. Systems and methods for performing endometrial ablation
US10179019B2 (en) 2014-05-22 2019-01-15 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
US9974599B2 (en) 2014-08-15 2018-05-22 Medtronic Ps Medical, Inc. Multipurpose electrosurgical device
US9956029B2 (en) 2014-10-31 2018-05-01 Medtronic Advanced Energy Llc Telescoping device with saline irrigation line
US11331037B2 (en) 2016-02-19 2022-05-17 Aegea Medical Inc. Methods and apparatus for determining the integrity of a bodily cavity
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
US20190365453A1 (en) * 2017-02-17 2019-12-05 Boston Scientific Scimed, Inc. System and method for limiting differential pressure across proportional valve during cryoablation procedures
US20190083298A1 (en) * 2017-09-21 2019-03-21 Michael W. Starkweather Whole body cryotherapy system
US11806066B2 (en) 2018-06-01 2023-11-07 Santa Anna Tech Llc Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems
US11864809B2 (en) 2018-06-01 2024-01-09 Santa Anna Tech Llc Vapor-based ablation treatment methods with improved treatment volume vapor management

Similar Documents

Publication Publication Date Title
US3924628A (en) Cyrogenic bladder for necrosing tissue cells
US10828080B2 (en) Regulating pressure to lower temperature in a cryotherapy balloon catheter
US9050074B2 (en) Cryosurgical fluid supply
US9402676B2 (en) Cryoablation balloon catheter and related method
AU2004308416B2 (en) Cryosurgical devices and methods for endometrial ablation
US5403309A (en) Cryosurgical ablation
CA2736221C (en) A cryogenic system and method of use
JP2004512075A (en) Multiple cryoprobe device and method
US3220414A (en) Surgical cannula
JP2020503977A (en) Apparatus for tissue surface ablation and related systems and methods
WO1994010948A1 (en) Heated balloon medical apparatus
US20210153920A1 (en) Apparatus and method for ablation of soft tissue surrounding a breast cavity following lumpectomy
CA1319072C (en) Intrauterine cauterizing apparatus and method